Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction
{{output}}
Interleukin 6 receptor (IL6R) inhibitor, tocilizumab, has been effectively used in the treatment of cytokine release syndrome in patients receiving chimeric antigen receptor T-cell therapy. Here we present a patient with chronic myelomonocytic leukemia (CMML) ... ...
